Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Pilot Efficacy Trial of Sunitinib for Refractory Malignant Ascites

NCT00796861 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.

NCT NCT00796861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00796861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Pilot Efficacy Trial of Sunitinib for Refractory Malignant Ascites
Lead sponsor
Milton S. Hershey Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2007
Completion date
April 30, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascites